% et% après !% [en% ligne].% SIDAWEB.% Disponible% sur% :% http, %2010.% 255%p.%% 5.%% Schwartz% M,% Castex% J.% La% découverte% du% virus% du% SIDA:% la% vérité% sur% « l'affaire% ,
%Paris%:%O.%Jacob,%2009.%207%p.%% 6.%% Le% Sida% dans% le% monde.% [en% ligne].% L'EXPRESS.fr.% Disponible% sur% :% http ,
Etude% comparative% de% deux% enquêtes% d'opinion% réalisées% auprès% des% patients% infectés% par% le% VIH% pour% l'accès% aux% médicaments% antirétroviraux% (printemps% 1997% ?% printemps% 1998)% à% Nantes.% J% Pharm% Clin, leDsidaDtueDdeDmoinsDenDmoinsDlaDbaisseDdesD decesDseDpoursuitDselonDleDministereDdeDlaDsanteDmaisDla_215187% (consulté% le% 21% février% 2014).% 8.%% Lepelletier% A%% 9.%% A% to% Z% of% antiretroviral% drugs% D% Combivir% (AZT/3TC).% [en% ligne].% Disponible% sur% :% http, pp.92-41730921, 1997. ,
% les% trithérapies% progressent% mais% restent% insuffisantes.% [en% ligne].% Le% Figaro% Disponible% sur% :% http://www.lefigaro.fr/sciences, 1008. ,
% seul% homme% à% avoir% guéri% du% sida.% [en% ligne].% Le% Monde.fr.% Disponible%sur%:%http://www.lemonde.fr/sante/article, 2012. ,
Global% epidemic% data% and% statistics.% [en% ligne].% WHO.% Disponible% sur% :% http, 102014. ,
Rapport% ONUSIDA% sur% l'épidémie% mondiale% de% SIDA.% 2012 ,
% Le% point% sur% l'épidémie% du% SIDA, 2009. ,
% les% chiffres% officiels.% [en% ligne].% Disponible% sur% :% http ,
Disponible% sur% :% http, 2013. ,
% HIV% and% AIDS% in% the% European% Union,% 2011.% [en% ligne].% Disponible% sur% :% http://www.eurosurveillance.org/ViewArticle.aspx?, p.20329, 102014. ,
%2003?08:%a% modelling%analysis.%Lancet%Infect%Dis.%2010%Oct, %% AIDES :%Première%association%française%de%lutte%contre%le%VIH%/%sida%et%les%hépatites, pp.682-689 ,
% 6% 372% personnes% ont% découvert% leur% séropositivité% au% VIH% en% 2012.% [en% ligne].% Disponible% sur% :% http, pp.6-372, 132014. ,
Transmission% sexuelle% de% l'infection% par% le% VIH.% Montrouge%, p.654 ,
%[en%ligne].%Disponible%sur%:%http://hivbook.com/category ,
%[en%ligne].% Disponible% sur% :% http, p.122, 2013. ,
VHC% et% le% VHB% chez% le% personnel% de% santé% en% France :% Données% au% 31% décembre%, p.2363188, 2005. ,
% Factors% Associated% with%MotherDtoDChild%Transmission%of%HIVD1%Despite%a%Maternal%Viral%Load%<500%Copies/mL% at%Delivery:%A%CaseDControl%Study%Nested%in%the%French%Perinatal%Cohort%(EPFDANRS%CO1).%Clin% Infect%Dis, pp.585-96, 201015. ,
%MotherDtoDchild% transmission% of% human% immunodeficiency% virus% in% aten% years% period.% Reprod% Health, p.35 ,
%Retroviridae:%The%Retroviruses%and%Their%Replication.%In%:%Knipe%DM,%Howley% PM,%eds.Fields%virology.He%edition ,
The% early% years% of% HIV% research:% integrating% clinical% and% basic% research.%Nat%Med.%2003%Jul, pp.844-850 ,
%History%of%the%discoveries%of%the%first%human%retroviruses:%HTLVD1%and%HTLVD 2.%Oncogene.%2005%Sep%5, pp.5926-5956 ,
Simian% foamy% virus% infection% in% humans:% prevalence% and% management.% Expert%Rev%Anti%Infect%Ther, pp.569-80, 2009. ,
Role% of% viral%regulatory%and%accessory%proteins%in%HIVD1%replication, pp.2388-413 ,
%Role%of%Human%Endogenous%Retroviral%Long%Terminal%Repeats%(LTRs)% in%Maintaining%the%Integrity%of%the%Human%Germ%Line.%Viruses.%2011%Jun%21, %% McCutchan%FE.%Global%epidemiology%of%HIV.%J%Med%Virol, vol.378, issue.1, pp.901-906, 2006. ,
% Glycosylation% in% HIVD1% envelope% glycoprotein% and% its% biological% implications, %Future%Virol, vol.8, issue.8, pp.783-800, 2013. ,
%% 50.%% Cashin%K,%Roche%M,%Sterjovski%J,%Ellett%A,%Gray%LR,%Cunningham%AL,%et%al.%Alternative% Coreceptor% Requirements% for% Efficient% CCR5D% and% CXCR4DMediated% HIVD1% Entry% into% Macrophages%, %J%Virol, vol.5385, issue.4D520, pp.201-510699, 2002. ,
% Molecular% strategies% to% inhibit% HIVD1% replication, Retrovirology, vol.2, issue.1, p.10, 200516. ,
DOI : 10.1186/1742-4690-2-10
Genetic Control of Retrovirus Susceptibility in Mammalian Cells, Annual Review of Genetics, vol.38, issue.1, pp.61-85, 2004. ,
DOI : 10.1146/annurev.genet.38.072902.094136
%TRIM5%structure,%HIVD1%capsid%recognition,%and%innate%immune% signaling, %Curr%Opin%Virol, vol.2, issue.2, pp.142-50, 2012. ,
%Viral%piracy:%HIVD1%targets%dendritic% cells%for%transmission.%Curr%HIV%Res, pp.169-76, 2006. ,
% DendriticDcell% interactions% with% HIV:% infection% and% viral% dissemination.%Nat%Rev%Immunol.%2006%Nov, pp.859-68 ,
Targeting early infection to prevent HIV-1 mucosal transmission, Nature, vol.183, issue.7286, pp.217-240, 201011. ,
DOI : 10.1371/journal.pmed.0050157
%Role%of% lymphoid% organs% in% the% pathogenesis% of% human% immunodeficiency% virus% (HIV)% infection, % Immunol%Rev, vol.140, pp.105-135, 1994. ,
%A%longDterm%latent%reservoir%for%HIVD1:%discovery%and%clinical% implications.%J%Antimicrob%Chemother.%2004%Jul, pp.6-9 ,
% Rapid% turnover% of% plasma% virions% and% CD4% lymphocytes% in% HIVD1% infection.% Nature, Jan%, vol.12373, issue.6510, pp.123-129, 1995. ,
% advance% online% publication.% Disponible% sur% :% http://www.nature.com/nature, 112014. ,
Delay% of% HIVD1% rebound% after% cessation% of% antiretroviral% therapy% through% passive% transfer% of% human% neutralizing%antibodies, %Nat%Med, vol.11, issue.6, pp.615-637, 2005. ,
%The%Humoral%Response%to%HIVD1:%New%Insights,%Renewed%Focus.%J% Infect%Dis%% WinMDI% et% l'immunologie.% [en% ligne].% Disponible% sur% :% http, S2):S315?S322.%% 72, 112014. ,
Mechanisms of CD4+ T lymphocyte cell death in human immunodeficiency virus infection and AIDS, Journal of General Virology, vol.84, issue.7, pp.1649-61, 20031. ,
DOI : 10.1099/vir.0.19110-0
% PDD1% expression% on% HIVDspecific% T% cells% is% associated% with% TDcell% exhaustion% and% disease% progression, %Nature, vol.443, issue.7109, pp.350-354, 200621. ,
HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells, HIV% nonprogressors% preferentially% maintain% highly% functional% HIVDspecific% CD8+% T% cells, pp.4781-4790, 200615. ,
DOI : 10.1182/blood-2005-12-4818
% Lymphocytes% T% cytotoxiques% spécifiques% du% virus% de% l'immunodéficience%humaine.%Virologie.%2001%Mar%2, pp.23-34 ,
Apoptosis% of% uninfected% cells% induced% by% HIV% envelope%glycoproteins.%Retrovirology.%2004%Jun%23, p.12 ,
Direct and indirect mechanisms mediating apoptosis during HIV infection: contribution to in vivo CD4 T cell depletion, Seminars in Immunology, vol.5, issue.3, pp.187-94, 1993. ,
DOI : 10.1006/smim.1993.1022
Immune% activation% and% inflammation% in% HIVD1% infection:% causes% and%consequences.%J%Pathol.%2008%Jan, pp.231-272 ,
%Changes%in%thymic% function% in% HIVDpositive% patients% treated% with% highly% active% antiretroviral% therapy% and% interleukinD2, %Clin%Exp%Immunol, vol.125, issue.3, pp.440-446, 2001. ,
%Cell%death%by% pyroptosis% drives% CD4% TDcell% depletion% in% HIVD1% infection, Nature.% 2014% Jan%, vol.23505, issue.7484, pp.509-523 ,
% a% diagnostic% assay% for% identifying% Iranian% HIV% seropositives, % Mol% Genet% Mikrobiol% Virusol.%, issue.3, pp.36-45, 2013. ,
The% Multispot%rapid%HIVD1/HIVD2%differentiation%assay%is%comparable%with%the%Western%blot%and% an% immunofluorescence% assay% at% confirming% HIV% infection% in% a% prospective% study% in% three% regions%of%the%United%States, %J%Clin%Virol, vol.58, pp.1-92, 2013. ,
Census% and% analysis% of% persistent% falseDnegative% results%in%serological%diagnosis%of%human%immunodeficiency%virus%type%1%group%O%infections, %J% Clin%Microbiol, vol.47, issue.9, pp.2906-2917, 2009. ,
% célèbre% méthode% pour% détecter% le% VIH.% [en% ligne].% FuturaD Sciences.% Disponible% sur% :% http://www.futuraD sciences.com/magazines/sante, 122014. ,
% [en% ligne].% 2013% Aug% 7.% Disponible% sur% :% http, 182014. ,
Actualités% sur% les% tests% rapides% d'orientation% diagnostique% de% l'infection% à% VIH%:% législation,% performances,% avantages% et% inconvénients, % ImmunoDAnal% Biol% Spéc, vol.28, issue.1, pp.8-17, 2013. ,
A% RealDTime% Comparison% in% a% Healthcare% Setting, % PLoS% ONE.% 2010% Jul%, vol.195, issue.7, pp.11581-128 ,
%Lyon%:%Presses%Universitaires%de%%Lyon,%2002.%798%p.%% 93.%% How%Does%a%Western%Blot%HIV%Test%Work?%[en%ligne].%About.com%Sexually%Transmitted% Diseases% (STDs).% Disponible% sur% :% http ,
Infection% à% VIH2 :% un% diagnostic% pas% toujours% évident.%Virologie.%2004%Mar%1%% 95.%% ECDCDHCUDE%editorial.%Symptomatic%primary%HIV%infection%in%a%49DyearDold%man%who% has% sex% with% men:% beware% of% the% window% phase, pp.153-158, 2014. ,
% [en% ligne].% Disabled% World.% Disponible% sur% :% http ,
% Isolation% of% HIVD1% from% monocytes% of% individuals% negative%by%conventional%culture.%J%Infect%Dis, pp.706-716, 1990. ,
Latent reservoirs of HIV: Obstacles to the eradication of virus, Proceedings of the National Academy of Sciences, vol.12, issue.17, pp.10958-61, 199928. ,
DOI : 10.1097/00002030-199817000-00002
%Direct%and%quantitative%detection%of%HIVD1%RNA% in% human% plasma% with% a% branched% DNA% signal% amplification% assay.% AIDS% Lond% Engl, pp.11-14, 1993. ,
% Relationship% Between% Residual% Plasma% Viremia% and% the% Size% of% HIV% Proviral% DNA% Reservoirs% in% Infected% Individuals% Receiving% Effective% Antiretroviral%Therapy.%J%Infect%Dis.%2011%Jul%1, %% 102.%% Masquelier%B,%Taieb%A,%Reigadas%S.%Cellular%HIVD1%DNA%quantification%and%shortDterm% and% longDterm% response% to% antiretroviral% therapy.% J% Antimicrob% Chemother.% 2011% Jul% 1, pp.135-81582 ,
%CD4%cell%count% and%HIV%DNA%level%are%independent%predictors%of%disease%progression%after%primary%HIV%type% 1% infection% in% untreated% patients.% Clin% Infect% Dis% Off% Publ% Infect% Dis% Soc% Am, Mar%, vol.142, issue.5, pp.709-724, 2006. ,
% [en% ligne].% Cold% Spring% Harb% Perspect% Med% Disponible% sur% :% http, 192014-04. ,
%Genotypic%and%phenotypic%characterization%of% HIVD1%isolates%obtained%from%patients%on%rilpivirine%therapy%experiencing%virologic%failure%in% the%phase%3%ECHO%and%THRIVE%studies:%48Dweek%analysis.%J%Acquir%Immune%Defic%Syndr%1999, %% 106.%% What's% New% in% the% Guidelines?% Adult% and% Adolescent% ARV% Guidelines.% [en% ligne, pp.39-46, 20121. ,
Disponible% sur% :% http://aidsinfo.nih.gov/guidelines, p.0, 122014. ,
% Disponible% sur% :% http ,
Les% virus% transmissibles% de% la% mère% à% l'enfant.% John% Libbey% Eurotext, 1999. ,
%Les%outils%du%dépistage%de%l'infection%par%le%VIH :%concepts,%progrès% et%limites.%Virologie.%2013%May%1, pp.171-81 ,
%Prognosis%in%HIVD 1% infection% predicted% by% the% quantity% of% virus% in% plasma.% Science, May%, vol.24272, issue.5265, pp.1167-70, 1996. ,
% Using% Plasma% Viral% Load% to% Guide% Antiretroviral% Therapy%Initiation%to%Prevent%HIVD1%Transmission, %PLoS%ONE, vol.7, issue.11, p.51192, 201230. ,
% Both% Serum%HIV%Type%1%RNA%Levels%and%CD4+%Lymphocyte%Counts%Predict%Clinical%Outcome%in%HIV% Type% 1DInfected% Subjects% with% 200% to% 500% CD4+% Cells% per% Cubic% Millimeter%% Thompson%MA,%Aberg%JA,%Cahn%P.%Antiretroviral%treatment%of%adult%hiv%infection:%2010% recommendations% of% the% international% aids% society?usa% panel, % AIDS% Res% Hum% Retroviruses. Jul%, vol.16304, issue.213, pp.645-53321, 2000. ,
% Combination% nucleoside/nucleotide% reverse% transcriptase% inhibitors% for% treatment% of% HIV% infection.% Expert% Opin% Pharmacother, %, vol.13, issue.1, pp.65-79, 2012. ,
%The%development%of%antiretroviral%therapy%and%its%impact%on%the%HIVD1/AIDS% pandemic.%Antiviral%Res.%2010%Jan, pp.1-18 ,
% Public% Health% Rationale% for% Rapid% Nucleic% Acid%or%p24%Antigen%Tests%for%HIV.%J%Infect%Dis.%2010%Apr%15, pp.7-15 ,
% Symptomatic% primary% infection% due% to% human%immunodeficiency%virus%type%1:%review%of%31%cases.%Clin%Infect%Dis%Off%Publ%Infect%Dis% Soc%Am, pp.59-65, 1993. ,
HIV% Infection.% Adult% and% Adolescent% ARV% Guidelines% [en% ligne].% AIDSinfo.% Disponible% sur% :% http://aidsinfo.nih.gov/guidelines, 2014. ,
% Clinical% presentation% and% diagnosis% of% primary% HIVD1% infection, %Curr%Opin%HIV%AIDS, vol.3, issue.1, pp.10-15, 2008. ,
%Screening%for%Acute%HIV%Infection:%Lessons%Learned.% Clin%Infect%Dis, pp.459-61, 20071. ,
% Human% immunodeficiency% virus% type% 1% variants% with% increased% replicative% capacity% develop% during% the% asymptomatic% stage% before% disease% progression, % J% Virol, vol.68, issue.7, pp.4400-4408, 19941. ,
% [en% ligne].% Health24.% Disponible% sur% :% http://www.health24.com, p.20130312, 202014. ,
Immunohistopathogenesis% of% persistent% generalized% lymphadenopathy%in%HIVDpositive%patients.%Ric%Clin%Lab.%1990%Mar, pp.1-10 ,
Progression% to% symptomatic% disease% in% people% infected% with% HIVD1% in% rural% Uganda:% prospective% cohort% studyCommentary:% Virus,% host,% or% environment?, %BMJ, vol.324, issue.7331, pp.193-200, 200226. ,
% Pulmonary% infections% in% HIVDinfected% patients:%an%update%in%the%21st%century, %Eur%Respir%J, vol.39, issue.3, pp.730-775, 20121. ,
% AIDS% and% the% lung% in% a% changing% world.% Thorax, 2001. ,
An% unusual% presentation% of% pulmonary% cryptococcosis% with% coDexisting% disseminated% tuberculosis% in% an% AIDS% patient, % Trop%Doct, vol.42, issue.1, pp.60-62, 20121. ,
Pulmonary aspergillosis: a clinical update, QJM, vol.100, issue.6, pp.317-351, 122014. ,
DOI : 10.1093/qjmed/hcm035
%In:%Li%H,%editor.%[en%ligne].%Radiology%of% HIV/AIDS.% Springer% Netherlands, pp.978-94, 1007. ,
Prevalence of HIV-related Pulmonary Arterial Hypertension in the Current Antiretroviral Therapy Era, American Journal of Respiratory and Critical Care Medicine, vol.177, issue.1, pp.108-121, 20081. ,
DOI : 10.1016/j.ehj.2004.09.014
% Cancer% as% a% cause% of% death% among% people% with% AIDS% in% the% United%States.%Clin%Infect%Dis%Off%Publ%Infect%Dis%Soc%Am.%2010%Oct%15, pp.957-62 ,
% HIV% infection% and% the% risk% of% cancers% with% and% without%a%known%infectious%cause.%AIDS%Lond%Engl.%2009%Nov%13, pp.2337-2382 ,
Neurologic Presentations of AIDS, Neurologic Clinics, vol.28, issue.1, pp.253-75, 2010. ,
DOI : 10.1016/j.ncl.2009.09.018
% Incidence% and% risk% factors% for% toxoplasmic% encephalitis% in% human% immunodeficiency% virusDinfected% patients% before% and% during% the% highly% active% antiretroviral% therapy%era.%Clin%Infect%Dis%Off%Publ%Infect%Dis%Soc%Am.%2001%Nov%15, pp.1747-55 ,
% Neurosyphilis% in% HIVD infected%patients:%clinical%manifestations,%serum%venereal%disease%research%laboratory%titers,% and%associated%factors%to%symptomatic%neurosyphilis.%Sex%Transm%Dis.%2008%May, pp.425-434 ,
% VaricellaDZoster% Virus:% Atypical% Presentations% and% Unusual% Complications.%J%Infect%Dis.%2002%Oct%15, S91?S98.%% 161.%% Watt%JJV%der, p.71 ,
Anemia% among% HIVDInfected% Patients% Initiating% Antiretroviral%Therapy%in%South%Africa:%Improvement%in%Hemoglobin%regardless%of%Degree%of% Immunosuppression% and% the% Initiating% ART% Regimen, 2013. ,
% Impact% on% hemoglobin% of% starting% combination% antiretroviral% therapy% with% or% without% zidovudine% in% anemic% HIVDinfected% patients.% J% Acquir% Immune%Defic%Syndr%1999, pp.163-171, 20081. ,
% HIVDassociated% anaemia% before% and% after% initiation% of% antiretroviral%therapy%at%Art%Centre%of%Minilik%II%Hospital,%Addis%Ababa,%Ethiopia.%Ethiop%Med% J.%2012%Jan, pp.13-21 ,
%Etiology%and%natural%history% of%neutropenia%in%human%immunodeficiency%virus%disease:%a%prospective%study.%Clin%Infect%Dis% Off%Publ%Infect%Dis%Soc%Am.%2001%Feb%1, pp.469-75 ,
% Neutropenia% in% human% immunodeficiency% virus% infection:% data% from% the% women's% interagency% HIV% study.% Arch% Intern% Med, Feb%, vol.27166, issue.4, pp.405-415, 2006. ,
%Neutropenia%and%human%immunodeficiency% virusD1% infection:% analysis% of% 43% cases.% Niger% J% Med% J% Natl% Assoc% Resid% Dr% Niger, pp.57-60, 2008. ,
Comparisons% of% anemia,% thrombocytopenia,% and% neutropenia%at%initiation%of%HIV%antiretroviral%therapy%in%Africa,%Asia,%and%the%Americas.%Int%J% Infect%Dis%IJID%Off%Publ%Int%Soc%Infect%Dis.%2010%Dec, pp.1088-1092611 ,
HIVDassociated% thrombotic% microangiopathy% in% the% era% of% highly% active% antiretroviral% therapy:% an% observational%study, %Clin%Infect%Dis%Off%Publ%Infect%Dis%Soc%Am, vol.39, issue.5, pp.267-275, 20041. ,
%Hemophagocytic%Lymphohistiocytosis%in%a%Patient%With%Recent%Initiation% of% HAART% Coinfected% With% Mycobacterium% avium% Complex% and% Disseminated% Histoplasmosis:%Who%Is%the%Culprit?%Infect%Dis%Clin%Pract.%2013%Nov, pp.389-91 ,
% and% antiretroviral%therapy%on%the%risk%of%individual%malignancies%(FHDHDANRS%CO4):%a%prospective% cohort%study.%Lancet%Oncol.%2009%Dec, %% % % % % 137%, pp.1152-9988 ,
Guidelines% for% the% Management% of% Chronic% Kidney% Disease% in% HIVDInfected% Patients:% Recommendations% of% the% HIV% Medicine% Association% of% the% Infectious% Diseases% Society% of%, America.%Clin%Infect%Dis, vol.40, issue.11, pp.1559-85, 20051. ,
% Oral% lesions% associated% with% HIV% infection% before% and% during% the% antiretroviral% therapy% era% in% Ribeirã, % J% Oral%Sci, vol.53, issue.3, pp.379-85, 2011. ,
Oral% manifestations% of% HIV% patients% in% South% Indian%population.%J%Pharm%Bioallied%Sci.%2012%Aug, pp.364-368 ,
% A% study% of% oral% lesions% among% HIV% positives% in% a% tertiary%care%hospital.%Biomed%ResDINDIA.%2013, pp.40-42 ,
% Oral% manifestations% of% HIV% infection% and% their% correlation%with%CD4%count.%J%Oral%Sci, pp.203-214, 2011. ,
Oral manifestations in human immunodeficiency virus infected patients, Indian Journal of Dermatology, vol.55, issue.1, pp.116-124, 2010. ,
DOI : 10.4103/0019-5154.60369
% [en% ligne].% Disponible% sur% :% http://www.directrelief.org/programmeD partenariatDdiflucan1, 222014. ,
% de% la% clinique% au% traitement.%Paris%:%Editions%Med'Com ,
Oral% and% Maxillofacial% Pathology:% A% Rationale% for% Diagnosis% and% Treatment ,
Prevalence of oral lesions in HIV infected adult population of Mangalore, Karnataka, India, BioDiscovery, 62014. ,
DOI : 10.7750/BioDiscovery.2012.4.3
% Optimal% management% of% oropharyngeal% and% esophageal% candidiasis% in% patients%living%with%HIV%infection.%HIVAIDS%Auckl%NZ.%2010%Apr%28, pp.89-101 ,
Oral% manifestations% associated% with% human% immunodeficiency% virus% infection% in% 200% Indian% patients.% [en% ligne% Disponible% sur% :% http, Bangladesh% J% Med% Sci.% 2010% Nov%, vol.229, issue.3, p.6470, 142014. ,
Oral lesions associated with HIV/AIDS in HIV-seropositive patients attending a counselling and treatment centre in Dar es Salaam, International Dental Journal, vol.12, issue.Suppl, pp.197-202, 2012. ,
DOI : 10.1111/j.1601-0825.2006.01232.x
% mise% au% point% et% utilisation% pratique.%J%Pharm%Clin.%2005%Sep%10, pp.145-57, 2005. ,
% [en% ligne].% Disponible% sur% :% http, 252014. ,
% OroDfacial% lesions% and% CD4% counts% associated% with% HIV/AIDS% in% an% adult% population% in% Oyo% State,% Nigeria, HIVDpositive%patients%in%a%specialized%service%in%Brazil.%J%Appl%Oral%Sci.% Oral% Dis.%, vol.1610, issue.66, pp.369-75, 2004. ,
Oro-facial lesions and CD4 counts associated with HIV/AIDS in an adult population in Oyo State, Nigeria, Oral Diseases, vol.69, issue.Suppl. 1, pp.319-345, 2004. ,
DOI : 10.1067/moe.2000.108799